Generic, Hospital, PBM, Insurer Groups To Congress: Probe Allergan IPR Deal

October 12, 2017 at 5:16 PM
A coalition that includes the trade groups for the generic, hospital, health insurance and pharmacy benefit manager industries are the latest to call on Congress to investigate Allergan's deal with a Mohawk tribe to skirt inter partes review of its patents. Allergan announced last month that it sold all of its all Orange Book-listed patents for its eye-drop product Restasis to a Mohawk tribe to dodge pending IPR challenges. Then on Sept. 22 the Mohawk tribe filed a motion to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.